Literature DB >> 15802330

Relationship between pulmonary function and lung cancer surgical outcome.

T Win1, A Jackson, L Sharples, A M Groves, F C Wells, A J Ritchie, C M Laroche.   

Abstract

The British Thoracic Society and American College of Chest Physician guidelines outline criteria for investigating patients for lung cancer surgery. However, the guidelines are based on relatively old studies. Therefore, the relationship between pulmonary function test results and surgical outcome were studied prospectively in a large cohort of lung cancer patients. From January 2001 to December 2003, 110 patients underwent surgery for lung cancer. All underwent full lung function testing in order to predict post-operative lung function. The hospital mortality rate was 3% and major complication rate 22%. There was poor overall outcome in 13%. Mean pre-operative lung function values were: forced expiratory volume in one second (FEV1) 2.0 L (79.4% of the predicted value), and carbon monoxide diffusing capacity of the lung (D(L,CO)) 73.6% pred. The mean post-operative lung function values were: FEV1 1.4 L (55.6% pred), and D(L,CO) 51.3% pred. All lung function values were better predictors of poor surgical outcome when expressed as a percentage of the predicted value. Using a threshold of pre-operative FEV1 of 47% pred resulted in the most useful positive and negative predictive probabilities, 0.90 and 0.67, respectively. Lung function values expressed as a percentage of the predicted value are more useful predictors of post-operative outcome than absolute values. The threshold of predicted forced expiratory volume in one second for surgical intervention could be lower (45-50% pred) than is currently accepted without increased mortality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15802330     DOI: 10.1183/09031936.05.00077504

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  23 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

2.  B-type natriuretic peptide-guided risk assessment for postoperative complications in lung cancer surgery.

Authors:  Takashi Nojiri; Masayoshi Inoue; Yasushi Shintani; Yukiyasu Takeuchi; Hajime Maeda; Toshimitsu Hamasaki; Meinoshin Okumura
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

Review 3.  Society for Translational Medicine Expert Consensus on the prevention and treatment of postoperative pulmonary infection in esophageal cancer patients.

Authors:  Zhentao Yu; Shanqing Li; Deruo Liu; Lunxu Liu; Jianxing He; Yunchao Huang; Shidong Xu; Weimin Mao; Qunyou Tan; Chun Chen; Xiaofei Li; Zhu Zhang; Gening Jiang; Lin Xu; Lanjun Zhang; Jianhua Fu; Hui Li; Qun Wang; Lijie Tan; Danqing Li; Qinghua Zhou; Xiangning Fu; Zhongmin Jiang; Haiquan Chen; Wentao Fang; Xun Zhang; Yin Li; Ti Tong; Yongyu Liu; Xiuyi Zhi; Tiansheng Yan; Xingyi Zhang; Lei Gong; Hongdian Zhang; John B Downs; Nestor Villamizar; Shugeng Gao; Jie He
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

4.  Impact of cardiopulmonary complications of lung cancer surgery on long-term outcomes.

Authors:  Takashi Nojiri; Masayoshi Inoue; Yukiyasu Takeuchi; Hajime Maeda; Yasushi Shintani; Noriyoshi Sawabata; Toshimitsu Hamasaki; Meinoshin Okumura
Journal:  Surg Today       Date:  2014-09-19       Impact factor: 2.549

5.  Long-acting muscarinic antagonist and long-acting β2-agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery.

Authors:  Takashi Makino; Hajime Otsuka; Yoshinobu Hata; Satoshi Koezuka; Yoko Azuma; Kazutoshi Isobe; Keishi Sugino; Satoru Ebihara; Sakae Homma; Akira Iyoda
Journal:  Mol Clin Oncol       Date:  2018-03-26

6.  Forced vital capacity predicts long-term survival for curative-resected NSCLC.

Authors:  Xi Guo; Hongxin Cao; Jun Xu; Jianyu Yu; Chunlong Zheng; Long Meng; Jiajun Du
Journal:  Med Oncol       Date:  2014-08-07       Impact factor: 3.064

7.  Six minute walking test and carbon monoxide diffusing capacity for non-small cell lung cancer: easy performed tests in every day practice.

Authors:  Paul Zarogoulidis; Theodora Kerenidi; Haidong Huang; Theodoros Kontakiotis; Ourania Tremma; Konstantinos Porpodis; Anastasios Kalianos; Ageliki Rapti; Christoforos Foroulis; Athanasios Zissimopoulos; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2012-12       Impact factor: 2.895

8.  Biopsy testing in an inoperable, non-small cell lung cancer population-a retrospective, real-life study in Sweden.

Authors:  Hirsh Koyi; Leif Johansson; Jesper From; Sven Nyrén
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

9.  Physiologic assessment before video thoracoscopic resection for lung cancer in patients with abnormal pulmonary function.

Authors:  Amira Benattia; David Debeaumont; Vincent Guyader; Catherine Tardif; Christophe Peillon; Antoine Cuvelier; Jean-Marc Baste
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

10.  Inhaled tiotropium to prevent postoperative cardiopulmonary complications in patients with newly diagnosed chronic obstructive pulmonary disease requiring lung cancer surgery.

Authors:  Takashi Nojiri; Masayoshi Inoue; Kazuhiro Yamamoto; Hajime Maeda; Yukiyasu Takeuchi; Tomoyuki Nakagiri; Yasushi Shintani; Masato Minami; Noriyoshi Sawabata; Meinoshin Okumura
Journal:  Surg Today       Date:  2013-01-10       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.